However, previous studies by our group report that in hepatosteatotic mouse models of ALD and NAFLD, FABP1 mRNA expression is unchanged compared to mice maintained on control diets [6]. This evidence concerns the gene FABP1 and metabolic dysfunction-associated steatotic liver disease.